US Patent Issued to Takeda Pharmaceutical on Aug. 5 for "Viral inhibitors, the synthesis thereof, and intermediates thereto" (Massachusetts, Florida, New Hampshire Inventors)

ALEXANDRIA, Va., Aug. 6 -- United States Patent no. 12,377,078, issued on Aug. 5, was assigned to Takeda Pharmaceutical Co. Ltd. (Osaka, Japan).

"Viral inhibitors, the synthesis thereof, and intermediates thereto" was invented by Jeffrey Scott Depue (Windham, N.H.), Suresh Kumar Tipparaju (Arlington, Mass.), Helge Alfred Reisch (Sarasota, Fla.), Datong Tang (Weston, Mass.) and Kishore Ramachandran (Westford, Mass.).

According to the abstract* released by the U.S. Patent & Trademark Office: "The present disclosure discloses compositions comprising maribavir, methods of providing the same, and compositions providing intermediates useful in providing maribavir. Maribavir (((2S,3S,4R,5S)-2-(5,6-dichloro-2-(isopropylamino)-1H-benzo[d]imidazol-...